A Study to Evaluate Infants With Potential Exposure to Tanezumab Before Birth

Clinical trial NCT01362660 · COMPLETED

Trial details

NCT number: NCT01362660
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Infant Developmental Assessment

Start date: 2011-06-01
Primary completion: 2012-06-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.